Literature DB >> 15232608

Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

Dennis W Dickson1.   

Abstract

Increasing evidence suggests that selective neuronal loss in neurodegenerative diseases involves activation of cysteine aspartyl proteases (caspases), which initiate and execute apoptosis. In Alzheimer disease both extracellular amyloid deposits and intracellular amyloid beta protein may activate caspases, leading to cleavage of nuclear and cytoskeletal proteins, including tau protein. Proteolysis of tau may be critical to neurofibrillary degeneration, which correlates with dementia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232608      PMCID: PMC437977          DOI: 10.1172/JCI22317

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

Review 1.  Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17.

Authors:  S H Yen; M Hutton; M DeTure; L W Ko; P Nacharaju
Journal:  Brain Pathol       Date:  1999-10       Impact factor: 6.508

2.  Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.

Authors:  J H Su; M Zhao; A J Anderson; A Srinivasan; C W Cotman
Journal:  Brain Res       Date:  2001-04-20       Impact factor: 3.252

Review 3.  Calpain and caspase: can you tell the difference?

Authors:  K K Wang
Journal:  Trends Neurosci       Date:  2000-01       Impact factor: 13.837

Review 4.  New frontiers in Alzheimer's disease genetics.

Authors:  R E Tanzi; L Bertram
Journal:  Neuron       Date:  2001-10-25       Impact factor: 17.173

5.  Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis.

Authors:  N Canu; L Dus; C Barbato; M T Ciotti; C Brancolini; A M Rinaldi; M Novak; A Cattaneo; A Bradbury; P Calissano
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

Review 6.  Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.

Authors:  C Glabe
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

7.  Memory and mental status correlates of modified Braak staging.

Authors:  E Grober; D Dickson; M J Sliwinski; H Buschke; M Katz; H Crystal; R B Lipton
Journal:  Neurobiol Aging       Date:  1999 Nov-Dec       Impact factor: 4.673

8.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

9.  Evidence for synaptic apoptosis.

Authors:  M P Mattson; J N Keller; J G Begley
Journal:  Exp Neurol       Date:  1998-09       Impact factor: 5.330

10.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Authors:  Michael K Lee; Wanda Stirling; Yanqun Xu; Xueying Xu; Dike Qui; Allen S Mandir; Ted M Dawson; Neal G Copeland; Nancy A Jenkins; Don L Price
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

View more
  50 in total

1.  Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.

Authors:  Ricardo Gomes; Marta Sousa Silva; Alexandre Quintas; Carlos Cordeiro; António Freire; Paulino Pereira; Américo Martins; Estela Monteiro; Eduardo Barroso; Ana Ponces Freire
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

2.  Amyloid, tau, and cell death in Alzheimer's disease.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-08-26

3.  Role of Bim in regulating CD8+ T-cell responses during chronic viral infection.

Authors:  Jason M Grayson; Ashley E Weant; Beth C Holbrook; David Hildeman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Beyond the skeleton: Cnidarian biomaterials as bioactive extracellular microenvironments for tissue engineering.

Authors:  Razi Vago
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

Review 5.  Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology.

Authors:  Bradley T Hyman; Junying Yuan
Journal:  Nat Rev Neurosci       Date:  2012-05-18       Impact factor: 34.870

Review 6.  Cnidarians biomineral in tissue engineering: a review.

Authors:  Razi Vago
Journal:  Mar Biotechnol (NY)       Date:  2008-05-15       Impact factor: 3.619

7.  Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?

Authors:  Troy T Rohn; Elizabeth Head
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

8.  Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

Authors:  Muthuswamy Anantharaman; Jitbanjong Tangpong; Jeffery N Keller; Michael P Murphy; William R Markesbery; Kelley K Kiningham; Daret K St Clair
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

10.  Amyloid-β(1-42) protofibrils formed in modified artificial cerebrospinal fluid bind and activate microglia.

Authors:  Geeta S Paranjape; Shana E Terrill; Lisa K Gouwens; Benjamin M Ruck; Michael R Nichols
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.